PODD today
$149.82-$0.21 (-0.14%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourStrong Bearish
15 minBearish
5 minDescending Triangle
Daily trend turns down below $128.01
Key levels
Resistance$161.35
Resistance$151.50
Support$143.31
Support$132.85
Latest news & SEC filings
ProductInsulet launches campaign for World Diabetes Day
AnalystTruist Securities keeps Hold rating on Insulet, lifts price target to $160
AnalystTruist Securities raises Insulet price target to $160 from $153
All PODD news →About Insulet
Insulet makes and sells wearable pumps that deliver insulin without tubing for patients whose diabetes requires insulin. Its Omnipod line covers the Omnipod 5 automated system, Omnipod DASH, and the older Classic Omnipod, and the company also builds pods for Amgen's Neulasta Onpro kit. Sales reach the United States and roughly two dozen other countries, largely via wholesalers and distributors, with some direct-to-consumer business, and are typically paid for by insurers and government health programs.
Based on the company's 10-K filed Feb 18, 2026.
Nasdaq · Healthcare
INSULET CORP (PODD)
What Is the Price Target for PODD?
SEPT Low Target
$144.00
SEPT Mid Target
$171.50
SEPT High Target
$200.00
Analyst Consensus
$171.50
Is PODD a Buy or Sell Right Now?
Thesis
- •Revenue growing 30.7% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PODD.
Start Free Trial →Is PODD Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$142.34
64
Moat Score
NARROW
7/9
Piotroski Score
6.0
Altman Z-Score
What Is Smart Money Doing with PODD?
Insider Signal
NEUTRAL
3 buys / 1 sells (90d)
Congress Signal
BUYING
3 buys / 3 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Pease Flavia | officer | Sale | 1,882 | $246K | Oct 1, 2026 |
| McEvoy Ashley | director officer | Buy | 1,100 | $162K | Aug 21, 2026 |
| Davis Lisa Blair | officer | Sale | 244 | $40K | Aug 1, 2026 |
| WEATHERMAN ELIZABETH H | director | Buy | 3,450 | $497K | Jun 3, 2026 |
| STONESIFER TIMOTHY C. | director | Buy | 2,790 | $400K | Jun 3, 2026 |
| BORIO LUCIANA | director | Sale | 418 | $60K | Jun 3, 2026 |
| WEATHERMAN ELIZABETH H | director | Buy | 1,660 | - | May 20, 2026 |
| STONESIFER TIMOTHY C. | director | Buy | 1,660 | - | May 20, 2026 |
| Scannell Timothy J | director | Buy | 1,660 | - | May 20, 2026 |
| MINOGUE MICHAEL R | director | Buy | 1,660 | - | May 20, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PODD Growth Story
Revenue YoY
30.7%
3yr Revenue CAGR
27.5%
EPS Growth YoY
-39.79%
FCF Growth YoY
23.7%
Revenue Trend
STRONG
Dark Pool Trades for PODD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PODD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:33:15 | $149.75 | 1,004 | $$150K | BUY |
| 20:32:44 | $149.63 | 8,558 | $$1.3M | BUY |
| 20:32:31 | $149.67 | 1,200 | $$180K | SELL |
| 20:28:49 | $149.63 | 3,095 | $$463K | BUY |
| 19:39:15 | $150.55 | 5,848 | $$880K | BUY |
5 dark pool trades shown · $$3.0M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PODD
PREVIEWSEPT Investing provides real-time options flow tracking for PODD, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $155 | Nov 20 | 8 | $$675 | 3 | SWEEP |
| CALL | $155 | Nov 20 | 8 | $$600 | 3 | SWEEP |
| CALL | $155 | Nov 20 | 8 | $$1000 | 5 | SWEEP |
| CALL | $155 | Nov 20 | 8 | $$198 | 1 | SWEEP |
| CALL | $155 | Nov 20 | 8 | $$198 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for INSULET CORP (PODD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PODD — frequently asked questions
What is PODD stock price today?
INSULET CORP (PODD) is at $149.82, down 0.14% (-$0.21) at the Nov 12, 2026 close.
Why is PODD stock moving today?
Latest PODD news — Nov 9, 2026: Insulet launches campaign for World Diabetes Day · Nov 9, 2026: Truist Securities keeps Hold rating on Insulet, lifts price target to $160
Why did PODD stock move on Nov 4, 2026?
Insulet shares surged 11.02% to close at $164.99 after the company reported third-quarter adjusted earnings of $1.99 per share and revenue of $842 million, both topping analyst forecasts. The medical device maker also announced a $1 billion share buyback and raised its full-year 2026 sales outlook to $3.277B-$3.304B with adjusted EPS expected above $6.46.
What is the PODD price target?
The average analyst price target for PODD is $171.50, ranging from $144 to $200, based on 16 analysts.
What do analysts rate PODD?
Analyst ratings for PODD: 15 Buy, 11 Hold, 0 Sell — consensus Buy.
Did PODD beat earnings?
PODD last reported on Nov 4, 2026: EPS $1.99 vs $1.59 expected — a beat of 25.2%.
What is PODD's P/E ratio?
PODD trades at a P/E of 23.9 vs a Healthcare average of 16.8.
Does PODD pay a dividend?
PODD does not currently pay a dividend.
What are PODD support and resistance levels?
Support: $143.31, $132.85, $126.40. Resistance: $151.50, $161.35, $168.47.
What are insiders doing with PODD?
Insider activity: NEUTRAL, 3 buys and 1 sells in the last 90 days.
What is the latest news on PODD?
Nov 9, 2026: Insulet launches campaign for World Diabetes Day · Nov 9, 2026: Truist Securities keeps Hold rating on Insulet, lifts price target to $160 · Nov 9, 2026: Truist Securities raises Insulet price target to $160 from $153